3D Systems (DDD) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for August 30, 2024, to be held virtually, with voting on four key proposals including director elections, executive compensation, incentive plan amendment, and auditor ratification.

• Company completed a four-phase transformation, focusing on Healthcare and Industrial Solutions, with ongoing restructuring in 2024 to drive innovation and long-term growth.

• Stockholders are encouraged to participate and vote electronically, by phone, or by mail.

Voting matters and shareholder proposals

• Election of nine directors for one-year terms; board reduced due to mandatory retirement age.

• Advisory vote on 2023 executive compensation (say-on-pay).

• Approval sought for amendment and restatement of the 2015 Incentive Plan, adding 4,000,000 shares and extending the plan to 2034.

• Ratification of Deloitte & Touche LLP as independent auditor for 2024.

Board of directors and corporate governance

• Board consists of nine members, eight of whom are independent; diverse backgrounds and skills represented.

• Board leadership is separated between Chair and CEO roles.

• Mandatory retirement age and 10-year term limits support board refreshment.

• Annual board and committee self-evaluations conducted for effectiveness.

• Five standing committees: Audit, Compensation, Corporate Governance and Sustainability, Compliance, and Technology Applications.